share_log
Moomoo 24/7 ·  Apr 18 07:32
Benitec Biopharma Reports Interim Clinical Trial Data For First OPMD Subject Treated With BB-301 In Phase 1b/2a Study; Says 'BB-301 Facilitated Improvements Across Multiple Measures of Swallowing Function in the First Phase 1b/2a Clinical Study Subject as Compared to Pretreatment Assessments Conducted During the Observational Natural History Portion of the Study'
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment